SEC Filing Analysis: SANGAMO THERAPEUTICS, INC (SGMO)

Executive Summary

• Trading Significance: Low
• Key Takeaway: A minor, non-discretionary sale by the Principal Accounting Officer to cover taxes on vested stock units.
• Market Impact: Neutral, as this is a routine, non-indicative transaction.

Company Information

Field	Value
Company	SANGAMO THERAPEUTICS, INC
Ticker Symbol	SGMO
CIK	0001001233
Industry	BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES)

Insider Information

Field	Value
Name	Jain Nikunj
CIK	0002089213
Title/Position	Principal Accounting Officer
Relationship	Officer

Transaction Details

Field	Value
Form Type	4
Transaction Date	2025-10-22
Transaction Code	F - Payment of tax liability by withholding securities
Security Type	Common Stock
Shares Involved	6,708
Price Per Share	$0.66
Total Value	$4,427.28
Shares Owned After	246,295
Ownership Type	Direct

Financial Impact Assessment

Transaction Materiality

Metric	Value
Transaction Value	$4,427.28
% of Market Cap	0.0023%
Shares Transacted	6,708
% of Shares Outstanding	0.0022%
Post-Transaction Ownership	246,295 shares (0.082% of outstanding)
Materiality Assessment	Low

Impact Evaluation

• Market Cap Context: The ~$4.4K transaction is insignificant for a company with a $190 million market capitalization.
• Ownership Concentration: The insider's post-transaction ownership of 0.082% is not a controlling stake and remains minimal.
• Dilution Impact: Not applicable. This is a disposition of existing shares, not an issuance of new equity.
• Transaction Significance: The transaction's low value and its nature as a mandatory tax withholding (Code 'F') render it insignificant for trading signals. It does not reflect the insider's sentiment towards the company's future prospects.

Market Impact Analysis

Stock Impact Prediction

• Direction: Neutral
• Reasoning: This is a routine, non-discretionary "sell-to-cover" transaction, which the market typically ignores as it provides no new information about the insider's confidence in the company.

Volume & Sentiment

• Expected Volume Impact: None. The shares were withheld by the issuer and not sold on the open market, so there is no impact on trading volume.
• Sentiment Indicator: Neutral

Investment Insights

Positive Market Indicators

• None can be derived from this filing.

Risk Factors

• None can be derived from this filing.

Key Takeaways

1. Non-Discretionary Action: The transaction was a mandatory tax withholding on vested RSUs, not a discretionary sale reflecting market sentiment.
2. Negligible Financial Impact: The value is extremely small ($4.4K) relative to the company's market cap ($190M) and shares outstanding.
3. No Indicative Value: This filing provides no insight into the insider's view on the company's current or future performance.

Additional Context

Transaction Notes

• Special Circumstances: The filing's footnote explicitly states this was a surrender of shares for mandatory tax withholding purposes and does not represent a discretionary trade by the reporting person.